Form 8-K - Current report:
SEC Accession No. 0000353569-22-000039
Filing Date
2022-05-04
Accepted
2022-05-04 16:27:02
Documents
15
Period of Report
2022-05-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K qdel-20220504.htm   iXBRL 8-K 51206
2 EX-99.1 qdel03312022exhibit991.htm EX-99.1 124528
7 qdel8k20image1a22a.jpg GRAPHIC 11058
  Complete submission text file 0000353569-22-000039.txt   376347

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT qdel-20220504.xsd EX-101.SCH 2247
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT qdel-20220504_def.xml EX-101.DEF 14507
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT qdel-20220504_lab.xml EX-101.LAB 28042
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT qdel-20220504_pre.xml EX-101.PRE 15006
9 EXTRACTED XBRL INSTANCE DOCUMENT qdel-20220504_htm.xml XML 11983
Mailing Address 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121
Business Address 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121 8585521100
QUIDEL CORP /DE/ (Filer) CIK: 0000353569 (see all company filings)

EIN.: 942573850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-10961 | Film No.: 22891944
SIC: 2835 In Vitro & In Vivo Diagnostic Substances